Parenchymal-sparing hepatectomy as the new doctrine in the treatment of liver-metastatic colorectal disease: Beyond oncological outcomes

Anticancer Research

Volumn 37, Issue 1, 2017, Pages 9-14

  Moris, Demetrios ^a   Dimitroulis, Dimitrios ^b   Vernadakis, Spiridon ^c   Papalampros, Alexandros ^b   Spartalis, Eleftherios ^c   Petrou, Athanasios ^b   Pawlik, Timothy M ^d   Felekouras, Evangelos ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Anatomical hepatectomy; Colorectal liver metastatic disease; Non anatomical hepatectomy; Parenchymal sparing hepatectomy; Review

Indexed keywords

CANCER SURGERY; CLINICAL TRIAL (TOPIC); COLORECTAL DISEASE; FINANCIAL DEFICIT; GOLD STANDARD; HUMAN; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; PARENCHYMAL SPARING HEPATECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; ADVERSE EFFECTS; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; LIVER NEOPLASMS; METASTASIS RESECTION; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR; SECONDARY;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; METASTASECTOMY; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 85007608273     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11283     Document Type: Review

References (39)

1. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN and Mahvi D: Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 13(10): 1271-1280, 2006.
2. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, Adam R, Castaing D and Azoulay D: Impact of expanding criteria for resectability of colorectal metastases on short-and long-term outcomes after hepatic resection. Ann Surg 253(6): 1069-1079, 2011.
3. Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, Ono Y and Kokudo N: Favorable outcome after repeat resection for colorectal liver metastases. Ann Surg Oncol 21(13): 4293-4299, 2014.
4. Eid S, Stromberg AJ, Ames S, Ellis S, McMasters KM and Martin RC: Assessment of symptom experience in patients undergoing hepatic resection or ablation. Cancer 107(11): 2715-2722, 2006.
5. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D and Adam R: Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248(6): 994-1005, 2008.
6. Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O, Filipponi F and Falcone A: Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13(1): 58-65, 2006.
7. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F and Bismuth H: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240(4): 644-657; discussion 657-648, 2004.
8. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM and Choti MA: Selection of patients for resection of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 13(10): 1261-1268, 2006.
9. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L and Vauthey JN: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5): 715-722, discussion 722-714, 2005.
10. Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN and Conrad C: Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg 263(1): 146-152, 2016.
11. Matsumura M, Mise Y, Saiura A, Inoue Y, Ishizawa T, Ichida H, Matsuki R, Tanaka M, Takeda Y and Takahashi Y: Parenchymalsparing hepatectomy does not increase intrahepatic recurrence in patients with advanced colorectal liver metastases. Ann Surg Oncol, 2016.
12. Oba M, Hasegawa K, Shindoh J, Yamashita S, Sakamoto Y, Makuuchi M and Kokudo N: Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases. Surgery 159(2): 632-640, 2016.
13. Wicherts DA, de Haas RJ, Salloum C, Andreani P, Pascal G, Sotirov D, Adam R, Castaing D and Azoulay D: Repeat hepatectomy for recurrent colorectal metastases. Br J Surg 100(6): 808-818, 2013.
14. Kulik U, Bektas H, Klempnauer J and Lehner F: Repeat liver resection for colorectal metastases. Br J Surg 100(7): 926-932, 2013.
15. Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Blumgart LH and D'Angelica M: Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: Trends in treatment over time in 440 patients. Ann Surg 247(1): 109-117, 2008.
16. Matsuki R, Mise Y, Saiura A, Inoue Y, Ishizawa T and Takahashi Y: Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases. Surgery, 2016.
17. Moris D, Dimitroulis D, Papalampros A, Petrou A and Felekouras E: Alpps procedure for hepatocellular carcinoma in patients with chronic liver disease: Revealing a terra incognita. Ann Surg, 2016.
18. Moris D, Vernadakis S, Papalampros A, Vailas M, Dimitrokallis N, Petrou A and Dimitroulis D: Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol 22(33): 7613-7624, 2016.
19. Alvarez FA, Sanchez Claria R, Oggero S and de Santibanes E: Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases. World J Gastrointest Surg 8(6): 407-423, 2016.
20. Banz VM, Inderbitzin D, Fankhauser R, Studer P and Candinas D: Long-term quality of life after hepatic resection: Health is not simply the absence of disease. World J Surg 33(7): 1473-1480, 2009.
21. Group EC: The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: Results from an international registry. Ann Surg 261(6): 1153-1159, 2015.
22. Tsilidis KK, Papadimitriou N, Capothanassi D, Bamia C, Benetou V, Jenab M, Freisling H, Kee F, Nelen A, O'Doherty MG, Scott A, Soerjomataram I, Tjonneland A, May AM, Ramon Quiros J, Pettersson-Kymmer U, Brenner H, Schottker B, Ordonez-Mena JM, Karina Dieffenbach A, Eriksson S, Bogeberg Mathiesen E, Njolstad I, Siganos G, Wilsgaard T, Boffetta P, Trichopoulos D and Trichopoulou A: Burden of cancer in a large consortium of prospective cohorts in Europe. J Natl Cancer Inst 108(10), 2016.
23. Bhalla A, Williams JP, Hurst NG, Speake WJ, Tierney GM, Tou S and Lund JN: One-third of patients fail to return to work 1 year after surgery for colorectal cancer. Tech Coloproctol 18(12): 1153-1159, 2014.
24. Martin RC, Eid S, Scoggins CR and McMasters KM: Healthrelated quality of life: Return to baseline after major and minor liver resection. Surgery 142(5): 676-684, 2007.
25. Wiering B, Oyen WJ, Adang EM, van der Sijp JR, Roumen RM, de Jong KP, Ruers TJ and Krabbe PF: Long-term global quality of life in patients treated for colorectal liver metastases. Br J Surg 98(4): 565-571; discussion 571-562, 2011.
26. LaPar DJ, Bhamidipati CM, Mery CM, Stukenborg GJ, Jones DR, Schirmer BD, Kron IL and Ailawadi G: Primary payer status affects mortality for major surgical operations. Ann Surg 252(3): 544-550; discussion 550-541, 2010.
27. Karidis NP, Dimitroulis D and Kouraklis G: Global financial crisis and surgical practice: The Greek paradigm. World J Surg 35(11): 2377-2381, 2011.
28. Moris D, Zavos G, Menoudakou G, Karampinis A and Boletis J: Organ donation during the financial crisis in Greece. Lancet 387(10027): 1511-1512, 2016.
29. Moris D, Felekouras E and Linos D: Global surgery initiative in Greece: More than an essential initiative. Lancet 388(10048): 957, 2016.
30. Gani F, Hundt J, Daniel M, Efron JE, Makary MA and Pawlik TM: Variations in hospitals costs for surgical procedures: Inefficient care or sick patients? Am J Surg, 2016.
31. Kulaylat AN, Schubart JR, Schaefer EW, Hollenbeak CS, Cooper AB and Gusani NJ: Costs of hepato-pancreato-biliary surgery and readmissions in privately insured us patients. J Surg Res 199(2): 478-486, 2015.
32. Tamandl D, Butte JM, Allen PJ, D'Angelica MI, DeMatteo RP, Groeger JS, Jarnagin WR and Fong Y: Hospital readmissions after liver surgery for metastatic colorectal cancer. Surgery 157(2): 231-238, 2015.
33. Kim Y, Gani F, Canner JK, Margonis GA, Makary MA, Schneider EB and Pawlik TM: Hospital readmission after multiple major operative procedures among patients with employer provided health insurance. Surgery 160(1): 178-190, 2016.
34. Spolverato G, Ejaz A, Kim Y, Weiss M, Wolfgang CL, Hirose K and Pawlik TM: Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre. HPB 16(11): 972-978, 2014.
35. Sutton JM, Hoehn RS, Ertel AE, Wilson GC, Hanseman DJ, Wima K, Sussman JJ, Ahmad SA, Shah SA and Abbott DE: Cost-effectiveness in hepatic lobectomy: The effect of case volume on mortality, readmission, and cost of care. J Gastrointest Surg 20(2): 253-261, 2016.
36. Page AJ, Gani F, Crowley KT, Lee KH, Grant MC, Zavadsky TL, Hobson D, Wu C, Wick EC and Pawlik TM: Patient outcomes and provider perceptions following implementation of a standardized perioperative care pathway for open liver resection. Br J Surg 103(5): 564-571, 2016.
37. Gani F, Hundt J, Makary MA, Haider AH, Zogg CK and Pawlik TM: Financial impact of postoperative complication following hepato-pancreatico-biliary surgery for cancer. Ann Surg Oncol 23(4): 1064-1070, 2016.
38. Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G and Pawlik TM: National trends in the use of surgery for benign hepatic tumors in the united states. Surgery 157(6): 1055-1064, 2015.
39. Nathan H, Segev DL, Mayo SC, Choti MA, Cameron AM, Wolfgang CL, Hirose K, Edil BH, Schulick RD and Pawlik TM: National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancer 118(7): 1838-1844, 2012.